AbCellera Biologics Inc (ABCL)
3.645
-0.14
(-3.57%)
USD |
NASDAQ |
May 17, 16:00
3.645
0.00 (0.00%)
After-Hours: 20:00
AbCellera Biologics Net Income (Quarterly): -40.61M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -40.61M |
| December 31, 2023 | -47.15M |
| September 30, 2023 | -28.61M |
| June 30, 2023 | -30.53M |
| March 31, 2023 | -40.11M |
| December 31, 2022 | -29.89M |
| September 30, 2022 | 26.62M |
| June 30, 2022 | -6.785M |
| March 31, 2022 | 168.57M |
| Date | Value |
|---|---|
| December 31, 2021 | 59.95M |
| September 30, 2021 | -21.38M |
| June 30, 2021 | -2.323M |
| March 31, 2021 | 117.22M |
| December 31, 2020 | 117.00M |
| September 30, 2020 | -2.693M |
| June 30, 2020 | 6.703M |
| March 31, 2020 | -2.093M |
| December 31, 2019 | -1.641M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-47.15M
Minimum
Dec 2023
168.57M
Maximum
Mar 2022
13.46M
Average
-2.508M
Median
Net Income (Quarterly) Benchmarks
| Acasti Pharma Inc | -2.391M |
| Aurinia Pharmaceuticals Inc | -26.88M |
| Edesa Biotech Inc | -1.861M |
| Lexaria Bioscience Corp | -0.6495M |
| InMed Pharmaceuticals Inc | -1.723M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 9.954M |
| Total Expenses (Quarterly) | 61.57M |
| EPS Diluted (Quarterly) | -0.14 |
| Enterprise Value | 372.34M |
| Profit Margin (Quarterly) | -408.0% |
| Earnings Yield | -14.29% |
| Normalized Earnings Yield | -14.29 |